Document:

RESALE REGISTRATION RIGHTS AGREEMENT

Exhibit 4.3

Resale Registration Rights Agreement

among

Quantum Corporation,

Lehman Brothers Inc.,

Morgan Stanley & Co. Incorporated

and

McDonald Investments Inc.

Dated as of July 30, 2003

TABLE OF CONTENTS

			
Page

	
1.

	
Definitions

	
1

	
2.

	
Shelf Registration

	
4

	
3.

	
Additional Amounts

	
4

	
4.

	
Registration Procedures

	
6

	
5.

	
Registration Expenses

	
12

	
6.

	
Indemnification and Contribution

	
13

	
7.

	
Rule 144A

	
16

	
8.

	
Participation in Underwritten Registrations

	
16

	
9.

	
Selection of Underwriters

	
16

	
10.

	
Miscellaneous

	
16

			

               Resale Registration Rights Agreement, dated as of July 30, 2003, among Quantum Corporation, a Delaware corporation
(together with any successor entity, herein referred to as the “Company”), and Lehman Brothers Inc., Morgan Stanley & Co. Incorporated and McDonald Investments Inc. (the “Initial Purchasers”).

 

                Pursuant to the Purchase Agreement, dated July 25, 2003, between the Company and the Initial Purchasers (the
“Purchase Agreement”), the Initial Purchasers have agreed to purchase from the Company $160,000,000 aggregate principal amount of 4.375% Convertible Subordinated Notes due 2010 (the “Notes”) ($184,000,000 aggregate principal
amount if the Initial Purchasers exercise in full their option to purchase additional Notes, as set forth in the Purchase Agreement).  The Notes initially will be convertible into fully paid, nonassessable common stock, par value $0.01 per share, of the
Company  (the “Common Stock”) on the terms, and subject to the conditions, set forth in the Indenture (as defined herein).  To induce the Initial Purchasers to purchase the Notes, the Company has agreed to provide the registration rights
set forth in this Agreement pursuant to the Purchase Agreement.

 

                The parties hereby agree as follows:

	
 

	
 

	
 

	
 

	
 

	
               

	
1.

	
Definitions.   As used in this Agreement, the following capitalized terms shall have the following meanings:

	
 

	
 

	
 

	
 

	
 

		
Additional Amounts:  As defined in Section 3(a) hereof.

	
 

	
 

	
 

	
 

	
 

		
Additional Amounts Payment Date:  Each Interest Payment Date.  For purposes of this Agreement, if no Notes are outstanding, “Additional Amounts Payment Date” shall mean, each February 1 and
August 1 commencing February 1, 2004.

	
 

	
 

	
 

	
 

	
 

		
Affiliate: As such term is defined in Rule 405 under the Securities Act.

	
 

	
 

	
 

	
 

	
 

		
Agreement:  This Resale Registration Rights Agreement, as amended, modified or otherwise supplemented from time to time in accordance with the terms hereof.

	
 

	
 

	
 

	
 

	
 

		
Blue Sky Application:  As defined in Section 6(a) hereof.

	
 

	
 

	
 

	
 

	
 

		
Broker-Dealer:  Any broker or dealer registered under the Exchange Act.

	
 

	
 

	
 

	
 

	
 

		
Business Day:  A day other than a Saturday or Sunday or any day on which banking institutions in New York City are authorized or obligated by law or executive order to close.

	
 

	
 

	
 

	
 

	
 

		
Closing Date:  The date of this Agreement.

	
 

	
 

	
 

	
 

	
 

		
Commission:  Securities and Exchange Commission.

	
 

	
 

	
 

	
 

	
 

		
Common Stock:  As defined in the preamble hereto.

	
 

	
 

	
 

	
 

	
 

		
Company:  As defined in the preamble hereto.

	

		
Effectiveness Period:  As defined in Section 2(a)(iii) hereof.

	
 

	
 

	
 

	
 

	
 

		
Effectiveness Target Date:  As defined in Section 2(a)(ii) hereof.

	
 

	
 

	
 

	
 

	
 

		
Exchange Act:  Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder.

	
 

	
 

	
 

	
 

	
 

		
Holder:  A Person who owns, beneficially or otherwise, Transfer Restricted Securities.

	
 

	
 

	
 

	
 

	
 

		
Indemnified Holder:  As defined in Section 6(a) hereof.

	
 

	
 

	
 

	
 

	
 

		
Indenture:  The Indenture, dated as of July 30, 2003, between the Company and U.S. National Bank Association as trustee, pursuant to which the Notes are to be issued, as such Indenture is amended, modified
or supplemented from time to time in accordance with the terms thereof.

	
 

	
 

	
 

	
 

	
 

		
Initial Purchasers:  As defined in the preamble hereto.

	
 

	
 

	
 

	
 

	
 

		
Interest Payment Date:  Each February 1 and August 1 of each year, commencing February 1, 2004.

	
 

	
 

	
 

	
 

	
 

		
Majority of Holders:  Holders holding more than 50% of the aggregate principal amount of Notes outstanding at the time of determination; provided that, for the purpose of this definition, a holder of
shares of Common Stock which constitute Transfer Restricted Securities when issued upon conversion of Notes shall be deemed to hold an aggregate principal amount of Notes (in addition to the principal amount of Notes held by such holder) equal to the product of (x)
the number of such shares of Common Stock received upon conversion of Notes then held by such holder and (y) the prevailing conversion price, such prevailing conversion price as determined in accordance with Section 12.1 of the Indenture.

	
 

	
 

	
 

	
 

	
 

		
NASD:  National Association of Securities Dealers, Inc.

	
 

	
 

	
 

	
 

	
 

		
NYSE: New York Stock Exchange.

	
 

	
 

	
 

	
 

	
 

		
Notes:  As defined in the preamble hereto.

	
 

	
 

	
 

	
 

	
 

		
Person:  An individual, partnership, corporation, unincorporated organization, limited liability company, trust, joint venture or a government or agency or political subdivision thereof.

	
 

	
 

	
 

	
 

	
 

		
Prospectus:  The prospectus included in a Shelf Registration Statement, as amended or supplemented by any prospectus supplement and by all other amendments thereto, including post-effective amendments, and
all material incorporated by reference into such Prospectus.

	
 

	
 

	
 

	
 

	
 

		
Purchase Agreement:  As defined in the preamble hereto.

	
2.

		
Questionnaire:  As defined in Section 2(b) hereof.

	
 

	
 

	
 

	
 

	
 

		
Record Holder:  With respect to any Additional Amounts Payment Date, each Person who is a Holder on the record date with respect to the Interest Payment Date on which such Additional Amounts Payment Date
shall occur, or if no Notes are outstanding, each January 15 and July 15, commencing on January 15, 2004.  In the case of a Holder of shares of Common Stock issued upon conversion of the Notes, “Record Holder” shall mean each Person who is a Holder
of shares of Common Stock which constitute Transfer Restricted Securities on the January 15th or July 15th preceding the relevant Additional Amounts Payment Date.

	
 

	
 

	
 

	
 

	
 

		
Registration Default:  As defined in Section 3(a) hereof.

	
 

	
 

	
 

	
 

	
 

		
Sales Notice:  As defined in Section 4(e) hereof.

	
 

	
 

	
 

	
 

	
 

		
Securities Act:  Securities Act of 1933, as amended, and the rules and resolutions of the Commission thereunder.

	
 

	
 

	
 

	
 

	
 

		
Shelf Filing Deadline: As defined in Section 2(a)(i) hereof.

	
 

	
 

	
 

	
 

	
 

		
Shelf Registration Statement:  As defined in Section 2(a)(i) hereof.

	
 

	
 

	
 

	
 

	
 

		
Suspension Period.  As defined in Section 4(b)(i) hereof.

	
 

	
 

	
 

	
 

	
 

		
TIA:  Trust Indenture Act of 1939, as amended, and the rules and regulations of the Commission thereunder, in each case, as in effect on the date the Indenture is qualified under the TIA.

3.

	
 

	
Transfer Restricted Securities:  Each Note and each share of Common Stock issued upon conversion of Notes until the earliest to occur of:

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
(i)

	
the date on which such Note or such shares of Common Stock issued upon conversion thereof has been effectively registered under the Securities Act and disposed of in accordance with the Shelf Registration
Statement; 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
(ii)

	
the date on which such Note or such shares of Common Stock issued upon conversion thereof (A) has been transferred in compliance with Rule 144 under the Securities Act or (B) may be sold or transferred by a person who is not
an Affiliate of the Company pursuant to Rule 144 under the Securities Act (or any other similar provision then in force) without any volume or manner of sale restrictions thereunder; or

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
(iii)

	
the date on which such Note or such shares of Common Stock issued upon conversion thereof ceases to be outstanding (whether as a result of redemption, repurchase and cancellation, conversion or otherwise).

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
Trustee:  As defined in Section 1.1 of the Indenture.

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
Underwritten Registration or Underwritten Offering:  A registration in which securities of the Company are sold to an underwriter for reoffering to the public.

	
 

	
 

	
 

	
 

	
 

	
 

	
               

	
2.

	
Shelf registration. 

	
 

	
 

	
 

	
 

	
 

	
 

		
(a)  The Company shall:

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
(i)

	
not later than 90 days after the date hereof (the “Shelf Filing Deadline”), cause to be filed a registration statement pursuant to Rule 415 under the Securities Act (together with any amendments thereto, and
including any documents incorporated by reference therein, the “Shelf Registration Statement”), which Shelf Registration Statement shall provide for resales of all Transfer Restricted Securities held by Holders that have provided the information
required pursuant to the terms of Section 2(b) hereof;

 

	
 

	
 

	
 

	
 

	
(ii)

	
use its reasonable efforts to cause the Shelf Registration Statement to be declared effective by the Commission not later than 180 days after the date hereof (the “Effectiveness Target Date”);
and 

	
 

	
 

	
 

	
 

	
(iii)

	
use its reasonable efforts to keep the Shelf Registration Statement continuously effective, supplemented and amended as required by the provisions of Section 4(b) hereof to the extent necessary to ensure that (A) it is
available for resales by the Holders of Transfer Restricted Securities entitled to the benefit of this Agreement and (B) conforms with the requirements of this Agreement and the Securities Act until the earliest to occur (the “Effectiveness
Period”) of:

	
 

	
 

	
 

	
 

	
 

	
(1)   two years following the last date of original issuance of Notes; or

	
	
 

	
 

	
 

	
 

	
				
(2)   the date when (x) all of the Holders of Transfer Restricted Securities (other than the Company and its Affiliates) are able to sell all Transfer Restricted Securities immediately pursuant to Rule 144(k)
under the Securities Act or any successor rule thereto, (y) when all Transfer Restricted Securities have ceased to be outstanding (whether as a result of redemption, repurchase and cancellation, conversion or otherwise) or (z) all Transfer Restricted Securities have
been registered under the Shelf Registration Statement and have been sold.

	
	
 

	
 

	
 

	
 

	
 

		
(b)  To have its Transfer Restricted Securities included in the Shelf Registration Statement pursuant to this Agreement, each Holder shall complete the Selling
Securityholder Notice and Questionnaire as specified in Section 4(d) hereof, the form of which is contained in Exhibit A to this Agreement (the “Questionnaire”). The Company shall mail the Questionnaire to Holders not later than 30 calendar days
prior to the date the Company intends, in good faith, to have the Shelf Registration Statement declared effective by the Commission. 

	
 

	
 

	
 

	
 

	
 

	
4.

	
               

	
3.

	
Additional Amounts.

	
 

	
 

	
 

	
 

	
 

	
 

		
(a)  If:

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
(i)

	
the Shelf Registration Statement is not filed with the Commission prior to or on the Shelf Filing Deadline; 

	
 

	
 

	
 

	
 

	
(ii)

	
the Shelf Registration Statement has not been declared effective by the Commission prior to or on the Effectiveness Target Date;

	
 

	
 

	
 

	
 

	
(iii)

	
except as provided in Section 4(b)(i) hereof, the Shelf Registration Statement is filed and declared effective but, during the Effectiveness Period, shall thereafter cease to be effective or fail to be usable for its intended
purpose without being succeeded within five Business Days by a post-effective amendment to the Shelf Registration Statement, a supplement to the Prospectus or a report filed with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act that
cures such failure and, in the case of a post-effective amendment, is itself immediately declared effective; or

	
 

	
 

	
 

	
 

	
(iv)

	
(A) prior to or on the 30th or 60th day, as the case may be, of any Suspension Period, such suspension has not been terminated or (B) Suspension Periods exceed an aggregate of 90 days in any 360 day
period,

	
 

	
 

	
(each such event referred to in foregoing clauses (i) through (iv), a “Registration Default”), the Company hereby agrees to pay additional amounts (“Additional Amounts”) with respect to
the Transfer Restricted Securities from and including the day following the Registration Default to but excluding the earliest to occur of (1) the day on which the Registration Default has been cured and (2) the date the Shelf Registration Statement is not longer
required to be kept effective, pursuant to Section 2(a), accruing at a rate:

	
	
 

	
 

	
 

	
 

	
   (A)   in respect of the Notes, to each holder of Notes, (x) with respect to the first 90-day period during which a Registration Default shall have occurred and be continuing, equal to 0.25% per
annum of the principal amount of the Notes, and (y) with respect to the period commencing on the 91st day following the day the Registration Default shall have occurred and be continuing, equal to 0.50% per annum of the principal amount of the Notes;
provided that in no event shall Additional Amounts accrue at a rate per year exceeding 0.50% of the principal amount of the Notes; and

	
 

	
 

	
 

	
 

	
   (B)   in respect of any shares of Common Stock issued upon conversion of the Notes, to each holder of shares of Common Stock, (x) with respect to the first 90-day period in which a Registration
Default shall have occurred and be continuing, equal to 0.25% per annum of the principal amount of the Notes converted into such shares of Common Stock and (y) with respect to the period commencing the 91st day following the day the Registration Default
shall have occurred and be continuing, equal to 0.50% per annum of the principal amount of the Notes converted into such shares of Common Stock; provided that in no event shall Additional Amounts accrue at a rate per year exceeding 0.50% of the principal
amount of the Notes converted into such shares of Common Stock.

	
 

	
 

	
 

	
 

	
 

	
5.

		
(b)  All accrued Additional Amounts shall be paid in arrears to Record Holders by the Company on each Additional Amounts Payment Date by wire transfer of
immediately available funds or by federal funds check.  Following the cure of all Registration Defaults relating to any particular Notes or shares of Common Stock issued upon conversion of Notes, the accrual of Additional Amounts with respect to such Notes or
such shares of Common Stock shall cease.  The Company agrees to deliver all notices, certificates and other documents contemplated by the Indenture in connection with the payment of Additional Amounts.

	
 

	
 

	
 

	
 

	
 

	
            No Additional Amounts shall accrue with respect to any Transfer Restricted Security from and after the earlier of the date on which such security cease to
be a Transfer Restricted Security and the expiration of the Effectiveness Period.  All obligations of the Company set forth in this Section 3 that are outstanding with respect to any Transfer Restricted Security at the time such security ceases to be a Transfer
Restricted Security shall survive until such time as all such obligations with respect to such Transfer Restricted Security shall have been satisfied in full.

	
 

	
 

	
 

	
 

	
 

	
            The Additional Amounts set forth above shall be the exclusive monetary remedy available to the Holders of Transfer Restricted Securities for such
Registration Default.

	
 

	
 

	
 

	
 

	
 

	
               

	
4.

	
Registration Procedures.

	
 

	
 

	
 

	
 

	
 

	
 

	
                (a)  In connection with the Shelf Registration
Statement, the Company shall comply with all the provisions of Section 4(b) hereof and shall use its reasonable efforts to effect such registration to permit the sale of the Transfer Restricted Securities being sold in accordance with the intended method or methods
of distribution thereof, and pursuant thereto, shall as expeditiously as possible prepare and file with the Commission a Shelf Registration Statement relating to the registration on any appropriate form under the Securities Act.

	
 

	
 

	
 

	
 

	
 

	
                (b)  In connection with the Shelf Registration
Statement and any Prospectus required by this Agreement to permit the sale or resale of Transfer Restricted Securities, the Company shall:

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
           (i)     Subject to any notice by the Company in accordance with this Section 4(b) of the existence of any fact or event of the kind
described in Section 4(b)(iii)(D) and the Company’s right to invoke a Suspension Period (as defined in below) in the manner described in this Section 4(b)(i), use its reasonable efforts to keep the Shelf Registration Statement continuously effective during the
Effectiveness Period; upon the occurrence of any event that would cause the Shelf Registration Statement or the Prospectus contained therein (A) to contain a material misstatement or omission or (B) not be effective and usable for resale of Transfer Restricted
Securities during the Effectiveness Period, unless a Suspension Period is then in effect the Company shall file promptly an appropriate amendment to the Shelf Registration Statement, a supplement to the Prospectus or a report filed with the Commission pursuant to
Section 13(a), 13(c), 14 or 15(d) of the Exchange Act, in the case of clause (A), correcting any such misstatement or omission, and, in the case of either clause (A) or (B), use its reasonable efforts to cause such amendment to be declared effective and the Shelf
Registration Statement and the related Prospectus to become usable for their intended purposes as soon as practicable thereafter.  Notwithstanding the foregoing, the Company may suspend the effectiveness of the Shelf Registration Statement by written notice to
the Holders for a period not to exceed an aggregate of 30 days in any 90-day period, or 90 days in any 360-day period (each such period, a “Suspension Period”), if:

	
 

	
 

	
 

	
 

	
 

	
6.

	
 

	
 

	
 

	
     (x)   an event occurs and is continuing as a result of which the Shelf Registration Statement would, in the Company’s reasonable judgment, contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; and

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
     (y)   the Company reasonably determines that the disclosure of such event at such time would have a material adverse effect on the business of the Company and its subsidiaries, taken as
a whole;

	
 

	
 

	
 

	
 

	
 

	
provided that, in the event the disclosure relates to a previously undisclosed proposed or pending material business transaction, the disclosure of which the Company’s board of directors determines would
impede the Company’s ability to consummate such transaction, the Company may extend a Suspension Period from 30 days to 60 days; provided, however, that Suspension Periods shall in no event exceed an aggregate of 90 days in any 360-day period.  The
Company shall not be required to specify in the written notice to the Holders the nature of the event giving rise to the Suspension Period.

	
 

	
 

	
 

	
 

	
           (ii)     Prepare and file with the Commission such amendments and post-effective amendments to the Shelf Registration Statement as may
be necessary to keep the Shelf Registration Statement effective during the Effectiveness Period; cause the Prospectus to be supplemented by any required Prospectus supplement, and as so supplemented to be filed pursuant to Rule 424 under the Securities Act, and to
comply fully with the applicable provisions of Rules 424 and 430A under the Securities Act in a timely manner; and comply with the provisions of the Securities Act with respect to the disposition of all securities covered by the Shelf Registration Statement during
the applicable period in accordance with the intended method or methods of distribution by the sellers thereof set forth in the Shelf Registration Statement or supplement to the Prospectus.

	
 

	
 

	
 

	
 

	
           (iii)     Advise the underwriter(s), if any, and selling Holders promptly (but in any event within three Business Days) and, if
requested by such Persons, to confirm such advice in writing:

	
 

	
 

	
 

	
 

	
 

	
                   (A) when the Prospectus or any Prospectus supplement or post-effective amendment has been filed, and, with
respect to the Shelf Registration Statement or any post-effective amendment thereto, when the same has become effective;

	
 

	
 

	
 

	
 

	
 

	
 

	
7.

	
 

	
 

	
 

	
                   (B) of any request by the Commission for amendments to the Shelf Registration Statement or amendments or
supplements to the Prospectus or for additional information relating thereto;

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
                   (C) of the issuance by the Commission of any stop order suspending the effectiveness of the Shelf
Registration Statement under the Securities Act or of the suspension by any state securities commission of the qualification of the Transfer Restricted Securities for offering or sale in any jurisdiction, or the initiation of any proceeding for any of the preceding
purposes; or

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
                   (D) of the existence of any fact or the happening of any event, during the Effectiveness Period (but not as
to the substance of any such fact or event), that makes any statement of a material fact made in the Shelf Registration Statement, the Prospectus, any amendment or supplement thereto, or any document incorporated by reference therein untrue, or that requires the
making of any additions to or changes in the Shelf Registration Statement or the Prospectus in order to make the statements therein not misleading.

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
      If at any time the Commission shall issue any stop order suspending the effectiveness of the Shelf Registration Statement, or any state securities commission or other regulatory authority
shall issue an order suspending the qualification or exemption from qualification of the Transfer Restricted Securities under state securities or Blue Sky laws, the Company shall use its reasonable efforts to obtain promptly the withdrawal or lifting of such order
and will provide to the Initial Purchasers and each Holder who is named in the Shelf Registration Statement prompt notice of the withdrawal of any such order.

	
 

	
 

	
 

	
 

	
           (iv)     If requested by any selling Holders or the underwriter(s), if any, promptly incorporate in the Shelf Registration Statement or
Prospectus, pursuant to a supplement or post‐effective amendment if necessary, such information as such selling Holders and underwriter(s), if any, may reasonably request to have included therein, including, without limitation: (1) information relating to the
“Plan of Distribution” of the Transfer Restricted Securities, (2) information with respect to the principal amount of Notes or number of shares of Common Stock issuable upon conversion of Notes being sold to such underwriter(s), (3) the purchase price
being paid therefor and (4) any other terms of the offering of the Transfer Restricted Securities to be sold in such offering; provided that with respect to any information requested for inclusion by a selling Holder, this clause (vi) shall apply only to
information that relates to the Transfer Restricted Securities to be sold by such selling Holder; and make all required filings of such Prospectus supplement or post‐effective amendment as soon as reasonably practicable after the Company is notified of the
matters to be incorporated in such Prospectus supplement or post‐effective amendment.

	
 

	
8.

	
 

	
 

	
           (v)     Furnish to each selling Holder and each of the underwriter(s), if any, without charge, at least one copy of the Shelf
Registration Statement, as first filed with the Commission, and of each amendment thereto (and any documents incorporated by reference therein or exhibits thereto (or exhibits incorporated in such exhibits by reference) as such Person may request).

	
 

	
 

	
 

	
           (vi)     Deliver to each selling Holder and each of the underwriter(s), if any, without charge, as many copies of the Prospectus
(including each preliminary prospectus) and any amendment or supplement thereto as such Persons reasonably may request; subject to any notice by the Company in accordance with this Section 4(b) of the existence of any fact or event of the kind described in Section
4(b)(iii) (D), the Company hereby consents to the use of the Prospectus and any amendment or supplement thereto by each of the selling Holders and each of the underwriter(s), if any, in connection with the offering and the sale of the Transfer Restricted Securities
covered by the Prospectus or any amendment or supplement thereto.

	
 

	
 

	
 

	
           (vii)     The Company shall:

	
 

	
 

	
 

	
           (A)     set forth in full in the underwriting agreement, if any, indemnification provisions and procedures which provide rights no less
protective than those set forth in Section 6 hereof with respect to all parties to be indemnified; and

	
 

	
 

	
 

	
           (B)     deliver such other documents and certificates as may be reasonably requested by such parties to evidence compliance with clause
(A) above and with any customary conditions contained in the underwriting agreement or other agreement entered into by the selling Holders pursuant to this clause (ix).

	
 

	
 

	
 

	
           (viii)     Before any public offering of Transfer Restricted Securities, cooperate with the selling Holders, the underwriter(s), if
any, and their respective counsel in connection with the registration and qualification of the Transfer Restricted Securities under the securities or Blue Sky laws of such jurisdictions in the United States as the selling Holders or underwriter(s), if any, may
reasonably request and do any and all other acts or things necessary or advisable to enable the disposition in such jurisdictions of the Transfer Restricted Securities covered by the Shelf Registration Statement; provided, however, that the Company shall not
be required (A) to register or qualify as a foreign corporation or a dealer of securities where it is not now so qualified or to take any action that would subject it to the service of process in any jurisdiction where it is not now so subject or (B) to subject
itself to taxation in any such jurisdiction if it is not now so subject.

	
 

	
 

	
 

	
           (ix)     Cooperate with the selling Holders and the underwriter(s), if any, to facilitate the timely preparation and delivery of
certificates representing Transfer Restricted Securities to be sold and not bearing any restrictive legends (unless required by applicable securities laws); and enable such Transfer Restricted Securities to be in such denominations and registered in such names as the
Holders or the underwriter(s), if any, may request at least two Business Days before any sale of Transfer Restricted Securities made by such underwriter(s).

	
 

	
9.

	
 

	
 

	
           (x)     Use its reasonable efforts to cause the Transfer Restricted Securities covered by the Shelf Registration Statement to be
registered with or approved by such other U.S. governmental agencies or authorities as may be necessary to enable the seller or sellers thereof or the underwriter(s), if any, to consummate the disposition of such Transfer Restricted Securities.

	
 

	
 

	
 

	
           (xi)     Subject to Section 4(b)(i) hereof, if any fact or event contemplated by Section 4(b)(iii)(D) hereof shall exist or have
occurred, use its reasonable efforts to prepare a supplement or post‐effective amendment to the Shelf Registration Statement or related Prospectus or any document incorporated therein by reference or file any other required document so that, as thereafter
delivered to the purchasers of Transfer Restricted Securities, the Prospectus will not contain an untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the
circumstances in which they were made, not misleading; provided that the Company shall not be required to comply with the obligations in this Section 4(b)(xiii) during any Suspension Period.

	
 

	
 

	
 

	
           (xii)     Provide CUSIP numbers for all Transfer Restricted Securities not later than the effective date of the Shelf Registration
Statement and provide the Trustee under the Indenture with certificates for the Notes that are in a form eligible for deposit with The Depository Trust Company.

	
 

	
 

	
 

	
           (xiii)     Cooperate and assist in any filings required to be made with the NASD and the NYSE and in the performance of any due
diligence investigation by any underwriter that is required to be retained in accordance with the rules and regulations of the NASD and the NYSE.

	
 

	
 

	
 

	
           (xiv)     Otherwise use its reasonable efforts to comply with all applicable rules and regulations of the Commission and all reporting
requirements under the Exchange Act.

	
 

	
 

	
 

	
           (xv)     Cause the Indenture to be qualified under the TIA not later than the effective date of the Shelf Registration Statement
required by this Agreement, and, in connection therewith, cooperate with the Trustee and the holders of Notes to effect such changes to the Indenture as may be required for such Indenture to be so qualified in accordance with the terms of the TIA; and execute and use
its reasonable efforts to cause the Trustee thereunder to execute all documents that may be required to effect such changes and all other forms and documents required to be filed with the Commission to enable such Indenture to be so qualified in a timely
manner.

	
 

	
 

	
 

	
           (xvi)     Cause all Common Stock covered by the Shelf Registration Statement to be listed or quoted, as the case may be, on each
securities exchange or automated quotation system on which similar securities issued by the Company are then listed or quoted.

	
 

	
10.

	
                (c)  Each Holder agrees by acquisition of a Transfer Restricted Security that, upon
receipt of any notice from the Company of the existence of any fact of the kind described in Section 4(b)(iii)(D) hereof, such Holder will, and will use its reasonable efforts to cause any underwriter(s) in an Underwritten Offering to, forthwith discontinue
disposition of Transfer Restricted Securities pursuant to the Shelf Registration Statement until:

	
 

	
 

	
 

	
           (i)     such Holder has received copies of the supplemented or amended Prospectus contemplated by Section 4(b)(xiii) hereof;
or.

	
 

	
 

	
 

	
           (ii)     such Holder is advised in writing by the Company that the use of the Prospectus may be resumed, and has received copies of any
additional or supplemental filings that are incorporated by reference in the Prospectus.

	
 

	
Each Holder agrees to keep the existence and receipt of a Suspension Notice confidential.  If so directed by the Company, each Holder will deliver to the Company (at the Company’s expense) all copies, other than
permanent file copies then in such Holder’s possession, of the Prospectus covering such Transfer Restricted Securities that was current at the time of receipt of such notice of suspension.

	
 

	
                (d)  Each Holder who intends to be named as a selling Holder in the Shelf Registration
Statement shall complete the Questionnaire and deliver it to the Company within 20 Business Days after the date of a written request therefor by the Company (which request shall include a copy of the Questionnaire).  Holders who do not complete the Questionnaire
and deliver it to the Company prior to effectiveness of the Shelf Registration Statement shall not be eligible to be named as selling securityholders in the Prospectus or preliminary Prospectus included in the Shelf Registration Statement at the time of effectiveness
thereof and, therefore, shall not be permitted to sell any Transfer Restricted Securities pursuant to the Shelf Registration Statement.  Upon receipt of a completed Questionnaire following the effectiveness of the Shelf Registration Statement, the Company shall
use its reasonable efforts to file, within 10 Business Days after such Questionnaire is received, any amendments or supplements to the Shelf Registration Statement or supplements to a related Prospectus as are necessary to allow such Holder to be named as a selling
Holder in the Prospectus included therein and to permit such Holder to transfer its Transfer Restricted Securities pursuant to the Shelf Registration Statement.  The Company shall pay the Additional Amounts described in Section 3(a) to such Holder in respect of
such Holder’s Transfer Restricted Securities if the Company fails to make such filings within such period or, if such filing is a post-effective amendment, if such amendment is not declared effective within 45 days of such filing.  Notwithstanding any of
the foregoing, the Company shall not be required to file more than one post-effective amendment to the Shelf Registration Statement in any fiscal quarter.  In addition, each Holder who intends to be named as a selling Holder in the Shelf Registration Statement
shall promptly respond to the Company by providing such other information as the Company may from time to time reasonably request in writing regarding the Holder and the proposed distribution by such Holder of its Transfer Restricted Securities in connection with the
Shelf Registration Statement or Prospectus or preliminary Prospectus included therein.

	
 

	
11.

	
                (e)  Upon the effectiveness of the Shelf Registration Statement, each Holder shall
notify the Company at least three Business Days prior to any intended distribution of Transfer Restricted Securities pursuant to the Shelf Registration Statement (a “Sale Notice”), which notice shall be effective for five Business Days.  Each
Holder of Transfer Restricted Securities, by accepting the same, agrees to hold any communication by the Company in response to a Sale Notice in confidence.

	
 

	
 

	
 

	
 

	
 

	
 

	
               

	
5.

	
Registration Expenses.

	
 

	
 

	
 

	
 

	
 

	
 

	
                (a)  All expenses incident to the Company’s performance of or compliance with
this Agreement shall be borne by the Company regardless of whether a Shelf Registration Statement becomes effective, including, without limitation:

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
           (i)     all registration and filing fees and expenses (including filings made by any Initial Purchasers or Holders with the
NASD);

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
           (ii)     all fees and expenses of compliance with federal securities and state Blue Sky or securities laws;

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
           (iii)     all expenses of printing (including printing of Prospectuses and certificates for the shares of Common Stock to be issued
upon conversion of the Notes) and the Company’s messenger and delivery services and telephone expenses;

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
           (iv)     all fees and disbursements of counsel to the Company and, subject to Section 5(b) below, the Holders of Transfer Restricted
Securities;

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
           (v)     all application and filing fees in connection with listing (or authorizing for quotation) the Common Stock issuable on
conversion of the Notes on a national securities exchange or automated quotation system pursuant to the requirements hereof; and

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
           (vi)     all fees and disbursements of independent certified public accountants of the Company (including the expenses of any special
audit and comfort letters required by or incident to such performance).

	
 

	
                The Company shall bear its internal expenses (including, without limitation, all salaries and expenses of its officers
and employees performing legal, accounting or other duties), the expenses of any annual audit and the fees and expenses of any Person, including special experts, retained by the Company.

	
 

	
                (b)  In connection with the Shelf Registration Statement required by this Agreement,
including any amendment or supplement thereto, and any other documents delivered to any Holders, the Company shall reimburse the Initial Purchasers and the Holders of Transfer Restricted Securities being registered pursuant to the Shelf Registration Statement, as
applicable, for the reasonable fees and disbursements of not more than one counsel, which shall be Simpson Thacher & Bartlett LLP, or such other counsel as may be chosen by a Majority of Holders for whose benefit the Shelf Registration Statement is being
prepared.  The Holders of Transfer Restricted Securities being registered shall be responsible for all underwriting commissions and discounts, if any, attributable to the sale of such Transfer Restricted Securities.

	
 

	
 

	
 

	
 

	
 

	
12.

	
               

	
6.

	
Indemnification and Contribution.

	
 

	
 

	
 

	
 

	
 

	
 

	
                (a)  The Company shall indemnify and hold harmless each Holder, such Holder’s officers, directors and
employees and each person, if any, who controls such Holder within the meaning of the Securities Act (each, an “Indemnified Holder”), from and against any loss, claim, damage or liability, joint or several, or any action in respect thereof
(including, but not limited to, any loss, claim, damage, liability or action relating to resales of the Transfer Restricted Securities), to which such Indemnified Holder may become subject, insofar as any such loss, claim, damage, liability or action arises out of,
or is based upon:

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
           (i)     any untrue statement or alleged untrue statement of a material fact contained in (A) the Shelf Registration Statement or
Prospectus or any amendment or supplement thereto or (B) any blue sky application or other document or any amendment or supplement thereto prepared or executed by the Company (or based upon written information furnished by or on behalf of the Company expressly for
use in such blue sky application or other document or amendment on supplement) filed in any jurisdiction specifically for the purpose of qualifying any or all of the Transfer Restricted Securities under the securities law of any state or other jurisdiction (such
application or document being hereinafter called a “Blue Sky Application”); or

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
           (ii)     the omission or alleged omission to state therein any material fact required to be stated therein or necessary to make the
statements therein, in the light of the circumstances under which they were made, not misleading,

	
 

	
 

	
 

	
 

	
 

	
and shall reimburse each Indemnified Holder promptly upon demand for any legal or other expenses reasonably incurred by such Indemnified Holder in connection with investigating or defending or preparing to defend against any
such loss, claim, damage, liability or action as such expenses are incurred; provided, however, that the Company shall not be liable in any such case to the extent that any such loss, claim, damage, liability or action arises out of, or is based upon,
(A) any untrue statement or alleged untrue statement or omission or alleged omission made in the Shelf Registration Statement or Prospectus or amendment or supplement thereto or Blue Sky Application or other document referred to in Section 6(a)(i) hereof in
reliance upon and in conformity with written information furnished to the Company by or on behalf of any Holder (or its related Indemnified Holder) specifically for use therein, or (B) the failure by the Holder or Indemnified Holder to deliver to any purchaser of its
Transfer Restricted Securities the Prospectus and any supplement or amendment thereto in the form provided to such Holder or Indemnified Holder by the Company if such Holder is required to so deliver pursuant to the prospectus delivery requirements of the Securities
Act.  The foregoing indemnity agreement is in addition to any liability which the Company may otherwise have to any Indemnified Holder.

	
 

	
 

	
 

	
 

	
 

	
                (b)  Each Holder, severally and not jointly, shall indemnify and hold harmless the
Company, its officers, directors and employees and each person, if any, who controls the Company within the meaning of the Securities Act, from and against any loss, claim, damage or liability, joint or several, or any action in respect thereof, to which the Company
or any such officer, director, employee or controlling person may become subject, insofar as any such loss, claim, damage or liability or action arises out of, or is based upon:

	
 

	
 

	
 

	
 

	
 

	
13.

	
 

	
 

	
           (i)     any untrue statement or alleged untrue statement of any material fact contained in the Shelf Registration Statement or
Prospectus or any amendment or supplement thereto or any Blue Sky Application or other document referred to in Section 6(a)(i) hereof; or

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
           (ii)     the omission or the alleged omission to state therein any material fact required to be stated therein or necessary to make the
statements therein, in light of the circumstances under which they were made, not misleading,

	
 

	
 

	
 

	
 

	
 

	
but in each case only to the extent that such untrue statement or alleged untrue statement or omission or alleged omission was made in reliance upon and in conformity with written information furnished to the Company by or on
behalf of such Holder (or its related Indemnified Holder) specifically for use therein, and shall reimburse the Company and any such officer, employee or controlling person promptly upon demand for any legal or other expenses reasonably incurred by the Company or any
such officer, employee or controlling person in connection with investigating or defending or preparing to defend against any such loss, claim, damage, liability or action as such expenses are incurred.  The foregoing indemnity agreement is in addition to any
liability which any Holder may otherwise have to the Company and any such officer, director, employee or controlling person.

	
 

	
 

	
 

	
 

	
 

	
                (c)  Promptly after receipt by an indemnified party under this Section 6 of notice of
any claim or the commencement of any action, the indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under this Section 6, notify the indemnifying party in writing of the claim or the commencement of that action;
provided, however, that the failure to notify the indemnifying party shall not relieve it from any liability which it may have under this Section 6 except to the extent it has been materially prejudiced by such failure and, provided, further, that the
failure to notify the indemnifying party shall not relieve it from any liability which it may have to an indemnified party otherwise than under this Section 6.  If any such claim or action shall be brought against an indemnified party, and it shall notify the
indemnifying party thereof, the indemnifying party shall be entitled to participate therein and, to the extent that it wishes, jointly with any other similarly notified indemnifying party, to assume the defense thereof with counsel satisfactory to the indemnified
party.  After notice from the indemnifying party to the indemnified party of its election to assume the defense of such claim or action, the indemnifying party shall not be liable to the indemnified party under this Section 6 for any legal or other expenses
subsequently incurred by the indemnified party in connection with the defense thereof other than reasonable costs of investigation; provided, however, that a Majority of Holders shall have the right to employ a single counsel to represent jointly a Majority of
Holders and their respective officers, directors, employees and controlling persons who may be subject to liability arising out of any claim in respect of which indemnity may be sought by a Majority of Holders against the Company under this Section 6, if a Majority
of Holders seeking indemnification shall have been advised by counsel that there may be one or more legal defenses available to them and their respective officers, employees and controlling persons that are different from or additional to those available to the
Company and its officers, directors, employees and controlling persons, the fees and expenses of a single separate counsel shall be paid by the Company.  No indemnifying party shall:

	
 

	
 

	
 

	
 

	
 

	
14.

	
 

	
 

	
           (i)     without the prior written consent of the indemnified parties (which consent shall not be unreasonably withheld) settle or
compromise or consent to the entry of any judgment with respect to any pending or threatened claim, action, suit or proceeding in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual or potential
parties to such claim or action) unless such settlement, compromise or consent includes an unconditional release of each indemnified party from all liability arising out of such claim, action, suit or proceeding; or

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
           (ii)     be liable for any settlement of any such action effected without its written consent (which consent shall not be unreasonably
withheld), but if settled with its written consent or if there be a final judgment for the plaintiff in any such action, the indemnifying party agrees to indemnify and hold harmless any indemnified party from and against any loss or liability by reason of such
settlement or judgment.

	
 

	
 

	
 

	
 

	
 

	
                (d)  If the indemnification provided for in this Section 6 shall for any reason be
unavailable or insufficient to hold harmless an indemnified party under Section 6(a) or 6(b) in respect of any loss, claim, damage or liability (or action in respect thereof) referred to therein, each indemnifying party shall, in lieu of indemnifying such indemnified
party, contribute to the amount paid or payable by such indemnified party as a result of such loss, claim, damage or liability (or action in respect thereof):

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
           (i)     in such proportion as is appropriate to reflect the relative benefits received by the Company from the offering and sale of the
Transfer Restricted Securities on the one hand and a Holder with respect to the sale by such Holder of the Transfer Restricted Securities on the other; or

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
           (ii)     if the allocation provided by clause (6)(d)(i) is not permitted by applicable law, in such proportion as is appropriate to
reflect not only the relative benefits referred to in clause 6(d)(i) but also the relative fault of the Company on the one hand and the Holders on the other in connection with the statements or omissions or alleged statements or alleged omissions that resulted in
such loss, claim, damage or liability (or action in respect thereof), as well as any other relevant equitable considerations.

	
 

	
 

	
 

	
 

	
 

	
The relative benefits received by the Company on the one hand and a Holder on the other with respect to such offering and such sale shall be deemed to be in the same proportion as the total net proceeds from the offering of
the Notes purchased under the Purchase Agreement (before deducting expenses) received by the Company on the one hand, bear to the total proceeds received by such Holder with respect to its sale of Transfer Restricted Securities on the other.  The relative fault
of the parties shall be determined by reference to whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company on the one hand or the Holders on the
other, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission.   The Company and each Holder agree that it would not be just and equitable if the amount of contribution
pursuant to this Section 6(d) were determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the first sentence of this paragraph (d).  The amount paid or payable by
an indemnified party as a result of the loss, claim, damage or liability, or action in respect thereof, referred to above in this Section 6 shall be deemed to include, for purposes of this Section 6, any legal or other expenses reasonably incurred by such indemnified
party in connection with investigating or defending or preparing to defend any such action or claim.  Notwithstanding the provisions of this Section 6, no Holder shall be required to contribute any amount in excess of the amount by which the total price at which
the Transfer Restricted Securities purchased by it were resold exceeds the amount of any damages which such Holder has otherwise been required to pay by reason of any untrue or alleged untrue statement or omission or alleged omission.  No person guilty of
fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.  The Holders’ obligations to contribute as provided in this
Section 6(d) are several and not joint.

	
 

	
 

	
 

	
 

	
 

	
15.

	
               

	
7.

	
Rule 144A.  In the event the Company is not subject to Section 13 or 15(d) of the Exchange Act, the Company hereby agrees with each Holder, for so long
as any Transfer Restricted Securities remain outstanding, to make available to any Holder or beneficial owner of Transfer Restricted Securities in connection with any sale thereof and any prospective purchaser of such Transfer Restricted Securities from such Holder
or beneficial owner, the information required by Rule 144A(d)(4) under the Securities Act in order to permit resales of such Transfer Restricted Securities pursuant to Rule 144A.

	
 

	
 

	
 

	
 

	
 

	
 

	
               

	
8.

	
Participation in Underwritten Registrations.     The Holders of Transfer Restricted Securities covered by the Shelf Registration Statement who
desire to do so may sell such Transfer Restricted Securities in an Underwritten Offering if approved by the Company in its sole discretion; provided, however, that no Holder may participate in any Underwritten Registration hereunder unless such Holder:

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
           (i)     agrees to sell such Holder’s Transfer Restricted Securities on the basis provided in any underwriting arrangements
approved by the Persons entitled hereunder to approve such arrangements; and

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
           (ii)     completes and executes all reasonable questionnaires, powers of attorney, indemnities, underwriting agreements, lock-up
letters and other documents required under the terms of such underwriting arrangements.

	
 

	
 

	
 

	
 

	
 

	
               

	
9.

	
Selection of Underwriters.    In any Underwritten Offering, the investment banker or investment bankers and manager or managers that will administer the offering
will be selected by a Majority of Holders whose Transfer Restricted Securities are included in such offering.

	
 

	
 

	
 

	
 

	
 

	
 

	
               

	
10.

	
Miscellaneous.

	
 

	
 

	
 

	
 

	
 

	
 

	
                (a)  Remedies.  The Company acknowledges and agrees that any failure by the Company to
comply with its obligations under Section 2 hereof may result in material irreparable injury to the Initial Purchasers or the Holders for which there is no adequate remedy at law, that it will not be possible to measure damages for such injuries precisely and that,
in the event of any such failure, the Initial Purchasers or any Holder may obtain such relief as may be required to specifically enforce the Company’s obligations under Section 2 hereof; provided that specific performance shall be the sole equitable
remedy available to Holders hereunder.  The Company further agrees to waive the defense in any action for specific performance that a remedy at law would be adequate.

	
 

	
 

	
 

	
 

	
 

	
16.

	
                (b)  Actions Affecting Transfer Restricted Securities.  The Company
shall not, directly or indirectly, take any action with respect to the Transfer Restricted Securities as a class that would adversely affect the ability of the Holders of Transfer Restricted Securities to include such Transfer Restricted Securities in a registration
undertaken pursuant to this Agreement.

	
 

	
 

	
 

	
 

	
 

	
                (c)  No Inconsistent Agreements.  The Company will not, on or after
the date of this Agreement, enter into any agreement with respect to its securities that is inconsistent with the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof.  In addition, the Company shall not grant to any
of its security holders (other than the Holders of Transfer Restricted Securities in such capacity) the right to include any of its securities in the Shelf Registration Statement provided for in this Agreement other than the Transfer Restricted Securities.  The
Company has not previously entered into any agreement (which has not expired or been terminated) granting any registration rights with respect to its securities to any Person which rights conflict with the provisions hereof.

	
 

	
 

	
 

	
 

	
 

	
                (d)  Amendments and Waivers.  This Agreement may not be amended,
modified or supplemented, and waivers or consents to or departures from the provisions hereof may not be given, unless the Company has obtained the written consent of a Majority of Holders or such greater percentage of the Holders as required by the
Indenture.

	
 

	
 

	
 

	
 

	
 

	
                (e)  Notices.  All notices and other communications provided for or
permitted hereunder shall be made in writing by hand‐delivery, first‐class mail (registered or certified, return receipt requested), telex, facsimile transmission, or air courier guaranteeing overnight delivery:

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
           (i)     if to a Holder, at the address set forth on the records of the registrar under the Indenture or the transfer agent of the
Common Stock, as the case may be; and

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
           (ii)     if to the Company:

                   Quantum Corporation

                    1650 Technology Drive, Suite 800,

                    San Jose, CA 95110

                    Attention:  General Counsel

                    Fax: (408) 944 4040

                    Telephone: (408 944 4000

                   With a copy to:

                   Wilson Sonsini Goodrich & Rosati, Professional Corporation

                    650 Page Mill Road

                    Palo Alto, CA 94304

                    Attention:  Steven Bochner, Esq.

                    Fax: (650) 493-8311

                    Telephone: (650) 493 9300

	
 

	
 

	
 

	
 

	
 

	
17.

	
                All such notices and communications shall be deemed to have been duly given: at the time delivered by hand, if personally
delivered; five Business Days after being deposited in the mail, postage prepaid, if mailed; when answered back, if telexed; when receipt acknowledged, if transmitted by facsimile; and on the next Business Day, if timely delivered to an air courier guaranteeing
overnight delivery.

	
 

	
 

	
 

	
 

	
 

	
                (f)  Successors and Assigns.  This Agreement shall inure to the
benefit of and be binding upon the successors and assigns of each of the parties, including, without limitation and without the need for an express assignment, subsequent Holders of Transfer Restricted Securities; provided, however, that (i) this Agreement
shall not inure to the benefit of or be binding upon a successor or assign of a Holder unless and to the extent such successor or assign acquired Transfer Restricted Securities from such Holder and (ii) nothing contained herein shall be deemed to permit any
assignment, transfer or other disposition of Transfer Restricted Securities in violation of the terms of the Purchase Agreement or the Indenture.  If any transferee of any Holder shall acquire Transfer Restricted Securities, in any manner, whether by operation
of law or otherwise, such Transfer Restricted Securities shall be held subject to all of the terms of this Agreement, and by taking and holding such Transfer Restricted Securities such person shall be conclusively deemed to have agreed to be bound by and to perform
all of the terms and provisions of this Agreement.

	
 

	
 

	
 

	
 

	
 

	
                (g)  Counterparts.  This Agreement may be executed in any number of
counterparts and by the parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement.

	
 

	
 

	
 

	
 

	
 

	
                (h)  Securities Held by the Company or its Affiliates.  Whenever the
consent or approval of Holders of a specified percentage of Transfer Restricted Securities is required hereunder, Transfer Restricted Securities held by the Company or its Affiliates shall not be counted in
determining whether such consent or approval was given by the Holders of such required percentage.

	
 

	
 

	
 

	
 

	
 

	
                (i)  Headings.  The headings in this Agreement are for convenience
of reference only and shall not limit or otherwise affect the meaning hereof.

	
 

	
 

	
 

	
 

	
 

	
                (j)  Governing Law.  This Agreement shall be governed by, and
construed in accordance with, the law of the State of New York.

	
 

	
 

	
 

	
 

	
 

	
                (k)  Severability.  If any one or more of the provisions contained
herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable, the validity, legality and enforceability of any such provision in every other respect and of the remaining provisions contained herein shall not be affected or
impaired thereby.

	
 

	
 

	
 

	
 

	
 

	
18.

	
                (l)  Confidentiality.  Notwithstanding anything in this Agreement to
the contrary, the Company and each prospective investor (and any employee, representative or other agent of the Company or any prospective investor) may disclose to any and all persons, without limitation of any kind, the tax treatment and tax structure of the
transactions contemplated by this Agreement and all materials of any kind (including opinions or other tax analyses) that are provided to it relating to such tax treatment and tax structure.  However, any such information relating to the tax treatment or tax
structure is required to be kept confidential to the extent necessary to comply with any applicable federal or state securities laws. 

	
 

	
 

	
 

	
 

	
 

	
                (m)  Entire Agreement.  This Agreement is intended by the parties as a final expression of
their agreement and intended to be a complete and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein.  There are no restrictions, promises, warranties or undertakings, other than those
set forth or referred to herein with respect to the registration rights granted by the Company with respect to the Transfer Restricted Securities.  This Agreement supersedes all prior agreements and understandings between the parties with respect to such subject
matter.

	
 

	
 

	
 

	
 

	
 

[SIGNATURE PAGE FOLLOWS]

19.

                In Witness Whereof, the parties have executed this Agreement as of the date first written above.

	
                                                                                         

	
QUANTUM CORPORATION

By   /s/ Michael Lambert                            

 Name: Michael Lambert

 Title: Executive Vice President and CFO

 

 

LEHMAN BROTHERS, INC.

 MORGAN STANLEY & CO. INCORPORATED

 MCDONALD INVESTMENTS INC.

By:

 LEHMAN BROTHERS INC.

By   /s/ Barbara M. Byrne                           

 Name: Barbara Byrne

 Title: Managing Director

 

MORGAN STANLEY & CO. INCORPORATED

By   /s/ Colm
Callan                                 

 Name: Colm Callan

 Title: Vice President

		

[SIGNATURE PAGE TO RESALE REGISTRATION RIGHTS AGREEMENT]

EXHIBIT A

QUANTUM CORPORATION

FORM OF SELLING SECURITYHOLDER NOTICE AND QUESTIONNAIRE

        The undersigned beneficial owner of 4.375% Convertible Subordinated Notes due 2010 (CUSIP No. 747906 AD 7) (the “Notes”), or common stock, par value $0.01
issuable upon conversion thereof (the “Common Stock” and together with the Notes, the “Transfer Restricted Securities”) of Quantum Corporation, a Delaware corporation (the “Company”), understands that the
Company has filed, or intends shortly to file, with the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-3 or such other form as may be available (the “Shelf Registration Statement”), for
the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Transfer Restricted Securities in accordance with the terms of the Resale Registration Rights Agreement, dated as of July 30, 2003
(the “Registration Rights Agreement”) among the Company, Lehman Brothers Inc., Morgan Stanley & Co. Incorporated and McDonald Investments Inc.  A copy of the Registration Rights Agreement is available from the Company upon request at the
address set forth below.  All capitalized terms not otherwise defined herein have the meaning ascribed thereto in the Registration Rights Agreement.

        Each beneficial owner of Transfer Restricted Securities is entitled to the benefits of the Registration Rights Agreement.  In order to sell or otherwise dispose of any
Transfer Restricted Securities pursuant to the Shelf Registration Statement, a beneficial owner of Transfer Restricted Securities generally will be required to be named as a selling securityholder in the related Prospectus, deliver a Prospectus to purchasers of
Transfer Restricted Securities and be bound by those provisions of the Registration Rights Agreement applicable to such beneficial owner (including certain indemnification rights and obligations, as described below).  Beneficial owners that do not complete this
Notice and Questionnaire and deliver it to Quantum will not be permitted to be named as selling securityholders in the prospectus included in the Shelf Registration statement at the time of effectiveness thereof and, therefore, will not be permitted to sell any
Transfer Restricted Securities pursuant to the Shelf Registration Statement.  The Company has obligations to use its reasonable efforts to name beneficial owners in the Shelf Registration Statement as selling securityholders in certain other circumstances
described in the Registration Rights Agreement.  The Company has agreed to pay additional amounts pursuant to the Registration Rights Agreement under certain circumstances as set forth therein.

        Upon any sale of Transfer Restricted Securities pursuant to a Shelf Registration Statement, the undersigned beneficial owner (the “Selling Securityholder”)
will be required to deliver to the Company and the trustee for the Notes the Notice to Transfer (completed and signed) set forth in Exhibit 1 to this Notice and Questionnaire.

        Certain legal consequences arise from being named as a selling securityholder in the Shelf Registration Statement and the related Prospectus.  Accordingly, holders and
beneficial owners of Transfer Restricted Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Shelf Registration Statement and the related
Prospectus.

A-1

NOTICE

        The undersigned beneficial owner (the “Selling Securityholder”) of Transfer Restricted Securities hereby gives notice to the Company of its intention to sell
or otherwise dispose of Transfer Restricted Securities beneficially owned by it and listed below in Item 3 (unless otherwise specified under Item 3) pursuant to the Shelf Registration Statement.  The undersigned, by signing and returning this Questionnaire,
understands that it will be bound by the terms and conditions of this Questionnaire and the Registration Rights Agreement.

        Pursuant to the Registration Rights Agreement, the undersigned has agreed to indemnify and hold harmless the Company, the Company’s directors, the Company’s officers
who sign the Shelf Registration Statement and each person, if any, who controls the Company within the meaning of either Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against certain losses arising in connection with statements
concerning the undersigned made in the Shelf Registration Statement or the related Prospectus in reliance upon the information provided in this Questionnaire.

The undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate and complete:

QUESTIONNAIRE

1.  Information Regarding Selling Securityholder

     (a)        Full legal name of Selling Securityholder:  _______________________

      (b)        Full legal name of registered holder (if not the same as (a) above) through which Transfer Restricted Securities listed in Item (3) below are
held:  __________________________________________________________

      (c)        Full legal name of DTC participant (if applicable and if not the same as (b) above) through which Transfer Restricted Securities listed in Item (3)
are held:  __________________________________________________

2.  Address for Notices to Selling Securityholders

     Telephone:  ____________________________

     Fax:  _________________________________

     Contact Person:  ________________________

3.  Beneficial Ownership of Transfer Restricted Securities

      (a)        Type of Transfer Restricted Securities beneficially owned, and principal amount of Securities or number of shares of Common Stock, as the case may
be, beneficially owned:  ____________________________

      (b)        CUSIP No(s). of such Transfer Restricted Securities beneficially owned:  ___________________

A-2

4.  Beneficial Ownership of the Company’s Securities Owned by the Selling
Securityholder

     Except as set forth below in this Item (4), the undersigned is not the beneficial or registered owner of any securities of the Company other than the Transfer Restricted Securities listed above in
Item (3) (“Other Securities”).

      (a)        Type and amount of Other Securities beneficially owned by the Selling Securityholder:  ____________________________________________

      (b)        CUSIP No(s). of such Other Securities beneficially owned:  _________________________________________________________

5.  Relationship with the Company

     Except as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (5% or more) has held any position or office or has had any other
material relationship with the Company (or its predecessors or affiliates) during the past three years.

     State any exceptions here:  _________________________

6.  Plan of Distribution

     Except as set forth below, the undersigned (including its donees or pledgees) intends to distribute the Transfer Restricted Securities listed above in Item (3) pursuant to the Shelf Registration
Statement only as follows (if at all).  Such Transfer Restricted Securities may be sold from time to time directly by the undersigned or, alternatively, through underwriters, broker‐dealers or agents.  If the Transfer Restricted Securities are sold
through underwriters or broker‐dealers, the Selling Securityholder will be responsible for underwriting discounts or commissions or agent’s commissions.  Such Transfer Restricted Securities may be sold in one or more transactions at fixed prices, at
prevailing market prices at the time of sale, at varying prices determined at the time of sale, or at negotiated prices.  Such sales may be effected in transactions (which may involve crosses or block transactions):

          (i)  on any national securities exchange or quotation service on which the Transfer Restricted Securities may be listed or quoted at the time of
sale;

          (ii)  in the over‐the‐counter market;

          (iii)  in transactions otherwise than on such exchanges or services or in the over‐the‐counter market; or

          (iv)  through the writing of options.

A-3

     In connection with sales of the Transfer Restricted Securities or otherwise, the undersigned may enter into hedging transactions with broker‐dealers, which may in turn engage in short sales
of the Transfer Restricted Securities and deliver Transfer Restricted Securities to close out such short positions, or loan or pledge Transfer Restricted Securities to broker‐dealers that in turn may sell such securities.

     State any exceptions here:  _____________________________________________

  _________________________________________________________________________

     Note:  In no event will such method(s) of distribution take the form of an underwritten offering of the Transfer Restricted Securities without the prior agreement of the
Company.

7.  Instructions for Delivery of Questionnaire

Please return the completed and executed Questionnaire to Quantum Corporation at:

Quantum Corporation

1650 Technology Drive

San Jose, CA 95110

Attention:  Mary Springer

Fax:  (408) 944-4040

8.  Acknowledgments

     The undersigned acknowledges that it understands its obligation to comply with the provisions of the Exchange Act and the rules and regulations promulgated thereunder relating to stock
manipulation, particularly Regulation M thereunder (or any successor rules or regulations), in connection with any offering of Transfer Restricted Securities pursuant to the Shelf Registration Statement.  The undersigned agrees that neither it nor any person
acting on its behalf will engage in any transaction in violation of such provisions.

     The Selling Securityholder hereby acknowledges its obligations under the Registration Rights Agreement to indemnify and hold harmless certain persons as set forth therein.  Pursuant to the
Registration Rights Agreement, the Company has agreed under certain circumstances to indemnify the Selling Securityholders against certain liabilities.

     In accordance with the undersigned’s obligation under the Registration Rights Agreement to provide such information as may be required by law for inclusion in the Shelf Registration
Statement, the undersigned agrees to promptly notify the Company of any inaccuracies or changes in the information provided herein that may occur subsequent to the date hereof at any time while the Shelf Registration Statement remains effective.  All notices
hereunder and pursuant to the Registration Rights Agreement shall be made in writing at the address set forth above.

     By signing below, the undersigned consents to the disclosure of the information contained herein in its answers to items (1) through (6) above and the inclusion of such information in the Shelf
Registration Statement and the related Prospectus. The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment of the Shelf Registration Statement and the related Prospectus.

A-4

     IN WITNESS WHEREOF, the undersigned, by authority duly given, has caused this Questionnaire to be executed and delivered either in person or by its duly authorized agent.

	
                                                                                               

	
Beneficial Owner

By: ________________________________

 Name:

 Title:

 Date:

		

A-5

EXHIBIT 1

NOTICE TO TRANSFER PURSUANT

TO REGISTRATION STATEMENT

Quantum Corporation

Re:  Quantum Corporation (the “Company”) 4.375% Convertible Subordinated Notes due 2010 (the “Notes”)

Dear Sirs:

     Please be advised that ________________has transferred $________________ aggregate principal amount of the above-referenced Notes of the Company or the common stock issued on conversion of the
Notes (the “Common Stock”), pursuant to the Registration Statement on Form S-3 (File No._____) filed by the Company.

     We hereby certify that the prospectus delivery requirements, if any, of the Securities Act of 1933, as amended, have been satisfied with respect to the transfer described above and the above named
beneficial owner of the Notes or the Common Stock is named as a selling securityholder in the prospectus dated _______, or in amendments or supplements thereto, and that the aggregate principal amount of the Notes or number of the Common Stock transferred are [all or
a portion of] the Notes or the Common Stock listed in such prospectus, as amended or supplemented, opposite such owner’s name.

	
                                                                                               

	
Beneficial Owner

Very truly yours,

 [name]

 By: ____________________________________

             (Authorized Signature)

Dated:Exhibit 4.4 - Notice of Transfer

Exhibit 4.4

NOTICE OF TRANSFER PURSUANT

TO REGISTRATION STATEMENT

U.S. Bank National Association

550 S. Hope Street, Suite 500

Los Angeles, California 90071

Attention: Corporate Trust Services

Quantum Corporation

1650 Technology Drive, Suite 800

San Jose, California, 95110

Attention: General Counsel

 

Re:    Quantum Corporation (the "Company") 4.375% Convertible Subordinated Notes due 2010 (the "Notes")

Dear Sirs:

Please be advised that                    has transferred
$                aggregate principal amount of the above-referenced Notes or the Company's Common Stock, issued on conversion of the Notes, pursuant to the Registration Statement on
Form S‐3 (File No.    ‐        ) filed by the Company.

We hereby certify that the prospectus delivery requirements, if any, of the Securities Act of 1933, as amended, have been satisfied with respect to the transfer described above and that the above-named beneficial owner of the
Notes or Common Stock is named as a selling securityholder in the Prospectus dated                , 2003 or in amendments or supplements thereto, and that the aggregate principal amount of the
Notes or number of shares of Common Stock transferred are [a portion of] the Notes or Common Stock listed in such Prospectus as amended or supplemented opposite such owner's name.

 

                                                                                                     Very
truly yours,

                                                                                                     
(Name)

                                                                                                     By:
                                          

                                                                                                     
    (Authorized Signature)

Dated:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00056-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00056-of-00352.parquet"}]]